Medlive Technology (2192.HK) Earnings Analysis
Medlive Technology (2192.HK) next reports earnings on 2026-09-01. Trailing P/E 14.21.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 2192.HK next report earnings?
| Next earnings date | 2026-09-01 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 0.42B |
2192.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-26 | 0.267 HKD | n/a | n/a | n/a |
| 2025-08-29 | 0.2296 HKD | n/a | n/a | n/a |
| 2025-03-24 | 0.2444 HKD | n/a | n/a | n/a |
2192.HK valuation and analyst view
| Trailing P/E | 14.21 |
|---|---|
| Trailing EPS | 0.45577 HKD |
| Price / book | 0.96 |
| Dividend yield | 3.92% |
| Market cap | 5.58B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Medlive Technology (2192.HK)'s next earnings date?
Medlive Technology is next scheduled to report on 2026-09-01 and revenue estimate of 0.42B.
Did 2192.HK beat earnings last quarter?
Consensus estimate data was not available for 2192.HK's 2026-03-26 report.
What is 2192.HK's current P/E ratio and EPS?
2192.HK trades at a trailing P/E of 14.21 on trailing EPS of 0.45577385754815014 HKD.
What do analysts rate 2192.HK?
2192.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.